$111.96 -1.95 (%) Johnson & Johnson - New York Stock Exchange, Inc.

Jan. 24, 2017 | 02:25 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Roche: A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield

    TalkMarkets | Jan. 24, 2017 | 12:36PM EST
  2. J&J HCV Dips To 'Virtually Zero,' Mirroring Gilead; 2017 Views Lag

    Investors Business Daily | Jan. 24, 2017 | 11:11AM EST
  3. Johnson & Johnson, Lockheed Martin Corporation Shares Fall After Weak Outlooks

    TalkMarkets | Jan. 24, 2017 | 10:12AM EST
  4. Why Real Risk Involves Valuation

    Dividend.com | Jan. 24, 2017 | 08:00AM EST
  5. Johnson & Johnson Slides On Top-Line Miss, Disappointing Drug Sales, Soft Outlook

    TalkMarkets | Jan. 24, 2017 | 07:46AM EST
  6. Year Of The Rooster

    TalkMarkets | Jan. 23, 2017 | 23:48PM EST
  7. How Will JNJ Investors React To Earnings?

    TalkMarkets | Jan. 23, 2017 | 17:51PM EST
  8. 5 Stocks To Watch Before The Market Opens Tomorrow - Tuesday, Jan. 24

    TalkMarkets | Jan. 23, 2017 | 17:11PM EST
  9. The Difference Between The Ex-Dividend Date, Record Date, And Pay Date

    TalkMarkets | Jan. 23, 2017 | 12:10PM EST
  10. Key Events In The Coming Week: All Eyes On Trump's First Actions

    TalkMarkets | Jan. 23, 2017 | 09:34AM EST
  11. The Market Glance for January 23: Trump’s First Week

    Dividend.com | Jan. 23, 2017 | 08:00AM EST
  12. Q4 Earnings Growth The Highest In 8 Quarters

    TalkMarkets | Jan. 21, 2017 | 18:44PM EST
  13. Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst

    Investors Business Daily | Jan. 19, 2017 | 16:41PM EST
  14. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily | Jan. 19, 2017 | 16:34PM EST
  15. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily | Jan. 19, 2017 | 13:06PM EST
  16. Johnson & Johnson Valuation – January 2017

    TalkMarkets | Jan. 16, 2017 | 11:41AM EST
  17. Trump + Stocks: The Week In Review

    TalkMarkets | Jan. 13, 2017 | 19:44PM EST
  18. Had to Happen

    TalkMarkets | Jan. 13, 2017 | 04:36AM EST
  19. PPL: Geographically Diversified Utility with 4.4% Yield & Long Dividend History

    TalkMarkets | Jan. 12, 2017 | 12:17PM EST
  20. Mr. Market And A Valuation Of The Dow For Value Investors – January 2017

    TalkMarkets | Jan. 9, 2017 | 11:09AM EST
  21. My 7 Favorite Dividend Health Care Stocks Today

    TalkMarkets | Jan. 5, 2017 | 16:38PM EST
  22. Shining A Spotlight On Ailing Health Care ETFs

    TalkMarkets | Jan. 5, 2017 | 05:02AM EST
  23. Dividend Income Update December 2016

    TalkMarkets | Jan. 5, 2017 | 04:52AM EST
  24. Immovable V. Unstoppable

    TalkMarkets | Jan. 4, 2017 | 23:45PM EST
  25. Medtronic Downgraded As Boston, J&J, St. Jude Rivalries Heat Up

    Investors Business Daily | Jan. 3, 2017 | 12:17PM EST
  26. Best 2017 U.S. Stock Picks

    TalkMarkets | Jan. 3, 2017 | 05:55AM EST
  27. 2017 Resolution; Know When to Buy/Sell

    TalkMarkets | Jan. 1, 2017 | 10:54AM EST
  28. 2017 Resolution: Know When to Buy/Sell

    TalkMarkets | Jan. 1, 2017 | 10:54AM EST
  29. Do Dividend Growth ETFs Really Grow?

    Dividend.com | Jan. 1, 2017 | 08:00AM EST
  30. Fitbit And Medtronic: Headlines Vs. Reality

    TalkMarkets | Dec. 30, 2016 | 08:55AM EST
  31. Stocks To Look Forward To In 2017

    TalkMarkets | Dec. 29, 2016 | 17:27PM EST
  32. Kevin O’Leary’s 10 Favorite Quality Dividend Stocks

    TalkMarkets | Dec. 29, 2016 | 16:46PM EST
  33. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets | Dec. 23, 2016 | 13:37PM EST
  34. The 10 Best Dividend Aristocrats for 2017 and Beyond

    TalkMarkets | Dec. 22, 2016 | 17:17PM EST
  35. Global Stocks Decline As Trading Volumes Collapse Ahead Of Monte Paschi Nationalization

    TalkMarkets | Dec. 22, 2016 | 06:42AM EST
  36. Best Dividend Paying Stocks for Dividend Growth Investors – December 2016

    TalkMarkets | Dec. 21, 2016 | 14:27PM EST
  37. Johnson In 'Exclusive' Talks To Acquire Actelion After Sanofi Fray

    Investors Business Daily | Dec. 21, 2016 | 13:30PM EST
  38. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  39. The 10 Best Dividend Achievers

    TalkMarkets | Dec. 14, 2016 | 17:52PM EST
  40. Stocks And Crude Slip, Bonds Rise Ahead Of Fed's Rate Hike Announcement

    TalkMarkets | Dec. 14, 2016 | 06:53AM EST
  41. Sanofi Seen In Talks With Actelion After J&J Bows Out

    Investors Business Daily | Dec. 13, 2016 | 23:54PM EST
  42. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets | Dec. 12, 2016 | 13:00PM EST
  43. December Dividend Stock Watch List

    TalkMarkets | Dec. 12, 2016 | 06:27AM EST
  44. Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key

    Investors Business Daily | Dec. 8, 2016 | 15:39PM EST
  45. What Comes After The Trump Rally?

    TalkMarkets | Dec. 8, 2016 | 00:17AM EST
  46. Trump Vow On Drug Prices Hammers Drug Stocks, But Key Indexes Up

    Investors Business Daily | Dec. 7, 2016 | 12:12PM EST
  47. Dow, S&P 500 Go Positive As Stocks Pare Losses; Dave & Buster's Pops 14%

    Investors Business Daily | Dec. 7, 2016 | 10:33AM EST
  48. Sanofi May Battle Johnson & Johnson For European Biotech Actelion

    Investors Business Daily | Dec. 6, 2016 | 12:01PM EST
  49. Stocks Futures Edge Higher; Cook: Apple Watch Doing Just Fine

    Investors Business Daily | Dec. 6, 2016 | 07:54AM EST
  50. Johnson & Johnson (JNJ) To Pay $1B For Defective Hip Implants

    TalkMarkets | Dec. 5, 2016 | 10:28AM EST
Trading Center